Ralf Bannemerschult

A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel over six treatment cycles

Ralf Bannemerschult, J. P. Hanker, Charles M. Wunsch et al. · Contraception · 1997 · 47 citations

Contraceptive Efficacy, Contraceptive Use, Contraception +15

Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 μg ethinylestradiol/100 μg levonorgestrel and 20 μg ethinylestradiol/500 μg norethisterone

Jan Endrikat, R. C. Hite, Ralf Bannemerschult et al. · Contraception · 2001 · 36 citations

Contraceptive Use, Infertility, Contraceptive Implants +15

Large observational trial of a new low-dose oral contraceptive containing 20 μg ethinylestradiol and 100 μg levonorgestrel (Miranova^r`) in Germany

R. C. Hite, Ralf Bannemerschult, P. Fox-Kuchenbecker et al. · The European Journal of Contraception & Reproductive Health Care · 1999 · 23 citations

Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population

Christoph Gerlinger, James Trussell, Uwe Mellinger et al. · Contraception · 2014 · 21 citations · Full text

Bleeding patterns with the 19.5 mg LNG-IUS, with special focus on the first year of use: implications for counselling

Vita Beckert, Christiane Ahlers, Ann-Kathrin Frenz et al. · The European Journal of Contraception & Reproductive Health Care · 2019 · 12 citations · Full text